Cha Eun-woo

Cha Eun-woo

Ask VT AI
View News Summary
  • A mixed bag of Q3 results, with a Sweden-based group and CBRE reporting stronger performance, while Tri Pointe Homes saw a weak quarter.
  • Moderna halts development of its experimental CMV vaccine after Phase III trial fails to meet primary endpoint, leaving the field without an approved congenital CMV vaccine.
  • Invitation Homes raises 2025 guidance after strong Q3 performance, with increased revenue, core FFO, and same-store metrics.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • A mixed bag of Q3 results, with a Sweden-based group and CBRE reporting stronger performance, while Tri Pointe Homes saw a weak quarter.
  • Moderna halts development of its experimental CMV vaccine after Phase III trial fails to meet primary endpoint, leaving the field without an approved congenital CMV vaccine.
  • Invitation Homes raises 2025 guidance after strong Q3 performance, with increased revenue, core FFO, and same-store metrics.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Cha Eun-woo